SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001193125-20-324618
Filing Date
2020-12-22
Accepted
2020-12-22 16:49:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B2 d23719d424b2.htm 424B2 143904
2 GRAPHIC g23719g1203092158289.jpg GRAPHIC 2695
3 GRAPHIC g23719g1203092158523.jpg GRAPHIC 4334
  Complete submission text file 0001193125-20-324618.txt   154998
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-251305 | Film No.: 201408649
SIC: 2834 Pharmaceutical Preparations